Skip to main content

Articles

Page 28 of 76

  1. Colorectal cancer (CRC), with a growing incidence trend worldwide, is resistant to apoptosis and has uncontrolled proliferation. It is recently reported that probiotic microorganisms exert anticancer effects. ...

    Authors: Zeinab Faghfoori, Mohammad Hasan Faghfoori, Amir Saber, Azimeh Izadi and Ahmad Yari Khosroushahi
    Citation: Cancer Cell International 2021 21:258
  2. This article has been retracted. Please see the Retraction Notice for more detail: https://doi.org/10.1186/s12935-021-01958-0

    Authors: Yang Hu, Hong Xie, Yankun Liu, Weiying Liu, Min Liu and Hua Tang
    Citation: Cancer Cell International 2021 21:255

    The original article was published in Cancer Cell International 2017 17:36

  3. Hepatocellular carcinoma is one of the most common malignant tumors worldwide and the fourth leading cause of cancer-related deaths. The prognosis of hepatocellular carcinoma patients is extremely poor due to ...

    Authors: Chenbin Liu, Han Wu, Yinqi Mao, Wei Chen and Shuying Chen
    Citation: Cancer Cell International 2021 21:254
  4. Regulatory factor X1 (RFX1) is an evolutionary conserved transcriptional factor that influences a wide range of cellular processes such as cell cycle, cell proliferation, differentiation, and apoptosis, by reg...

    Authors: Joby Issac, Pooja S. Raveendran and Ani V. Das
    Citation: Cancer Cell International 2021 21:253
  5. The role of HHLA2, a new immune checkpoint ligand, is gradually being elucidated in various solid tumours. However, its role in ovarian cancer remains unclear; thus, its expression profile and clinical signifi...

    Authors: Guocai Xu, Yuanyuan Shi, Xiaoting Ling, Dongyan Wang, Yunyun Liu, Huaiwu Lu, Yongpai Peng and Bingzhong Zhang
    Citation: Cancer Cell International 2021 21:252
  6. Bladder cancer is the leading causes of cancer-associated mortality and seriously affects population health. Hypoxia plays a key role in tumor development and immune escape, which contributes to malignant beha...

    Authors: Xianchao Sun, Zhen Zhou, Ying Zhang, Jinyou Wang, Xiaofeng Zhao, Liang Jin, Tingshuai Zhai, Xiang Liu, Jiaxin Zhang, Wangli Mei, Bihui Zhang, Ming Luo, Xudong Yao and Lin Ye
    Citation: Cancer Cell International 2021 21:251
  7. The hsa_circ_0004771 derived from NRIP1 (called circ_NRIP1) is a recently identified oncogenic circRNA. Here, we intended to investigate the role and mechanism of circ_NRIP1 in esophageal squamous cell carcino...

    Authors: Shifan Zhou, Zhizhong Guo, Chaofeng Zhou, Yu Zhang and Sai Wang
    Citation: Cancer Cell International 2021 21:250
  8. An amendment to this paper has been published and can be accessed via the original article.

    Authors: Guocai Tian, You Fu, Dahe Zhang, Jiang Li, Zhiyuan Zhang and Xi Yang
    Citation: Cancer Cell International 2021 21:248

    The original article was published in Cancer Cell International 2021 21:167

  9. In vivo imaging using fluorescence is used in cancer biology for the detection, measurement and monitoring of tumours. This can be achieved with the expression of fluorescent proteins such as iRFP, which emits...

    Authors: C. Hall, Y. von Grabowiecki, S. P. Pearce, C. Dive, S. Bagley and P. A. J. Muller
    Citation: Cancer Cell International 2021 21:247
  10. Renal clear cell carcinoma (ccRCC) is one of the most common malignant tumors, whose incidence is increasing year by year. IRF6 plays an important role in the occurrence of tumors, although there is yet no rep...

    Authors: Xinwei Ma, Xiaoqi Wang, Qian Dong, Hongquan Pang, Jianming Xu, Junkang Shen and Jianbing Zhu
    Citation: Cancer Cell International 2021 21:246
  11. Osteosarcoma patients often experience poor outcomes despite chemotherapy treatment, likely due in part to various mechanisms of tumor cell innate and/or acquired drug resistance. Exosomes, microvesicles secre...

    Authors: Marcus A. Weinman, Stephen A. Ramsey, Haley J. Leeper, Jacqueline V. Brady, Andrew Schlueter, Stanislau Stanisheuski, Claudia S. Maier, Tasha Miller, Carl E. Ruby and Shay Bracha
    Citation: Cancer Cell International 2021 21:245
  12. Several oncolytic viruses applications have been approved in the clinic or in different phases of clinical trials. However, these methods have some rudimentary problems. Therefore, to enhance the delivery and ...

    Authors: Seyed-Mahmood Seyed-Khorrami, Hoorieh Soleimanjahi, Sara Soudi and Ala Habibian
    Citation: Cancer Cell International 2021 21:244
  13. S100A11 is a member of the S100 family of proteins containing two EF-hand calcium-binding motifs. The dysregulated expression of the S100A11 gene has been implicated in tumour metastasis. However, the role of ...

    Authors: Yuxin Cui, Liting Li, Zhilei Li, Jie Yin, Jane Lane, Jiafu Ji and Wen G. Jiang
    Citation: Cancer Cell International 2021 21:243
  14. Bladder cancer is a frequently diagnosed urinary system tumor, whose mortality remains rising. Minichromosome maintenance eight homologous recombination repair factor (MCM8), a newly discovered MCM family memb...

    Authors: Wei Zhu, Fei Gao, Hongyi Zhou, Ke Jin, Jianfeng Shao and Zhuoqun Xu
    Citation: Cancer Cell International 2021 21:242
  15. Although miR-190 has been reported to be related to human diseases, especially in the development and progression of cancer, its expression in human bladder cancer (BC) and potential contribution to BC remain ...

    Authors: Shirui Huang, Xiaohui Hua, Mengjiao Kuang, Junlan Zhu, Haiqi Mu, Zhongxian Tian, Xiaoqun Zheng and Qipeng Xie
    Citation: Cancer Cell International 2021 21:241
  16. An amendment to this paper has been published and can be accessed via the original article.

    Authors: Jianhui Liu, Shaoliang Zhu, Wei Tang, Qinghua Huang, Yan Mei and Huawei Yang
    Citation: Cancer Cell International 2021 21:240

    The original article was published in Cancer Cell International 2021 21:55

  17. Programmed death-1/programmed death ligand-1 (PD-1/PD-L1) based immunotherapy is a revolutionary cancer therapy with great clinical success. The majority of clinically used PD-1/PD-L1 inhibitors are monoclonal...

    Authors: Chang Liu, Navindra P. Seeram and Hang Ma
    Citation: Cancer Cell International 2021 21:239
  18. Colon cancer is a malignant gastrointestinal tumour with high incidence, mortality and metastasis rates worldwide. Aloe-emodin is a monomer compound derived from hydroxyanthraquinone. Aloe-emodin produces a wi...

    Authors: Dongxiao Jiang, Shufei Ding, Zhujun Mao, Liyan You and Yeping Ruan
    Citation: Cancer Cell International 2021 21:238
  19. An amendment to this paper has been published and can be accessed via the original article.

    Authors: Zhenming Jiang, Yuxi Zhang, Xi Chen, Pingeng Wu and Dong Chen
    Citation: Cancer Cell International 2021 21:237

    The original article was published in Cancer Cell International 2019 19:271

  20. Prostate cancer is the most common malignant tumor of male genitourinary system, molecular mechanism of which is still not clear. PSMC2 (proteasome 26S subunit ATPase 2) is a key member of the 19S regulatory s...

    Authors: Qingke Chen, Lingmin Fu, Jieping Hu, Guanghua Guo and An Xie
    Citation: Cancer Cell International 2021 21:235
  21. Non-small cell lung cancer (NSCLC) is a common malignancy around the globe. Increasing long non-coding RNAs (lncRNAs) have been confirmed to be associated with the progression of cancers, including NSCLC. Long...

    Authors: Yanchao Deng, Liwei Zhang and Ruiying Luo
    Citation: Cancer Cell International 2021 21:234
  22. Invasive bladder tumors cause a worse prognosis in patients and remain a clinical challenge. Epithelial–mesenchymal transition (EMT) is associated with bladder cancer metastasis. In the present research, we at...

    Authors: Yaoyao Xiong, Xiongbing Zu, Long Wang, Yuan Li, Minfeng Chen, Wei He and Lin Qi
    Citation: Cancer Cell International 2021 21:233
  23. Anoikis resistance plays a critical role in the tumor metastasis by allowing survival of cancer cells in the systemic circulation. We previously showed that long non-coding RNAs APOC1P1-3 (lncRNA APOC1P1-3) in...

    Authors: Qi Lu, Li Wang, Yabiao Gao, Ping Zhu, Luying Li, Xue Wang, Youping Jin, Xiuling Zhi, Jerry Yu, Xin Li, Xingjun Qin and Ping Zhou
    Citation: Cancer Cell International 2021 21:232
  24. Immune cells account for a large proportion of the tumour microenvironment in anaplastic thyroid carcinomas (ATCs). However, the expression pattern of immune-related genes (IRGs) in ATCs is unclear. Our study ...

    Authors: Xuemin Wang, Wen Peng, Chunyan Li, Rujia Qin, Zhaoming Zhong and Chuanzheng Sun
    Citation: Cancer Cell International 2021 21:231
  25. T-cell acute lymphoblastic leukemia (T-ALL) is an aggressive disease with a high risk of induction failure and poor outcomes, with relapse due to drug resistance. Recent studies show that bromodomains and extr...

    Authors: Shuiyan Wu, You Jiang, Yi Hong, Xinran Chu, Zimu Zhang, Yanfang Tao, Ziwei Fan, Zhenjiang Bai, Xiaolu Li, Yanling Chen, Zhiheng Li, Xin Ding, Haitao Lv, Xiaoli Du, Su Lin Lim, Yongping Zhang…
    Citation: Cancer Cell International 2021 21:230
  26. Lung adenocarcinoma (LUAD) is the leading cause of cancer-related death. This study aimed to develop and validate reliable prognostic biomarkers and signature.

    Authors: Cui Zhao, Jian Liu, Haomiao Zhou, Xin Qian, Hui Sun, Xuewen Chen, Miaosen Zheng, Tingting Bian, Lei Liu, Yifei Liu and Jianguo Zhang
    Citation: Cancer Cell International 2021 21:228
  27. The purpose of this study is to explore the effect of miRNA-539 on osteosarcoma (OS) and the underlying mechanism, so as to find a new method for early diagnosis and treatment of osteosarcoma.

    Authors: Huowen Liu, Min Yang, Yufeng Zhang, Zhiqiang Yang, Zhe Chen, Yuanlong Xie, Binglong Peng and Lin Cai
    Citation: Cancer Cell International 2021 21:227
  28. Urothelial carcinoma (UC) is the second most common malignancy of the urinary system with high rate of recurrence, UC patients therefore needed to be treated with surgery followed by chemotherapy. Development ...

    Authors: Yeong-Chin Jou, Guan-Ling Lin, Hon-Yi Lin, Wan-Hong Huang, Yu-Ming Chuang, Ru-Inn Lin, Pie-Che Chen, Shu-Fen Wu, Cheng-Huang Shen and Michael W. Y. Chan
    Citation: Cancer Cell International 2021 21:226
  29. Intrahepatic cholangiocarcinoma (iCCA) is the second most common malignant hepatic tumor and has a high postoperative recurrence rate and a poor prognosis. The key roles of most tumor recurrence-associated mol...

    Authors: Fengwei Li, Qinjunjie Chen, Yang Yang, Meihui Li, Lei Zhang, Zhenlin Yan, Junjie Zhang and Kui Wang
    Citation: Cancer Cell International 2021 21:225
  30. We aimed to understand the clinical characteristics and better predict the prognosis of patients with mucosal melanoma of the head and neck (MMHN) using a nomogram.

    Authors: Qing-Qing Xu, Qing-Jie Li, Liu Chen, Xin-Yi Su, Jing-Xia Song, Juan Du, Lei Chen and Li-Xia Lu
    Citation: Cancer Cell International 2021 21:224
  31. Clear cell renal cell carcinoma (ccRCC) has been the commonest renal cell carcinoma (RCC). Although the disease classification, diagnosis and targeted therapy of RCC has been increasingly evolving attributing ...

    Authors: Xiaoqin Zhang, Ziyue Wang, Zixin Zeng, Ningning Shen, Bin Wang, Yaping Zhang, Honghong Shen, Wei Lu, Rong Wei, Wenxia Ma and Chen Wang
    Citation: Cancer Cell International 2021 21:222
  32. MicroRNAs (miRNAs) are a class of small noncoding RNA molecules containing only 20–22 nucleotides. MiRNAs play a role in gene silencing and translation suppression by targeting and binding to mRNA. Proper cont...

    Authors: Yufei Tang, Shaoqi Zong, Hailun Zeng, Xiaofeng Ruan, Liting Yao, Susu Han and Fenggang Hou
    Citation: Cancer Cell International 2021 21:221
  33. Serine hydroxymethyltransferase 2 (SHMT2) is a vital metabolic enzyme in one carbon metabolism catalyzing the conversion of serine to glycine, which has been reported to play a crucial role in the progression ...

    Authors: Yan Liao, Fang Wang, Yadong Zhang, Hongshi Cai, Fan Song and Jinsong Hou
    Citation: Cancer Cell International 2021 21:220
  34. Given that dysregulated metabolism has been recently identified as a hallmark of cancer biology, this study aims to establish and validate a prognostic signature of lung adenocarcinoma (LUAD) based on metaboli...

    Authors: Zhihao Wang, Kidane Siele Embaye, Qing Yang, Lingzhi Qin, Chao Zhang, Liwei Liu, Xiaoqian Zhan, Fengdi Zhang, Xi Wang and Shenghui Qin
    Citation: Cancer Cell International 2021 21:219
  35. Lung adenocarcinoma (LUAD) metastasis significantly reduces patient survival; hence inhibiting the metastatic ability of lung cancer cells will greatly prolong patient survival. Alkaline phosphatase (ALPL), a ...

    Authors: Zhefeng Lou, Weiwei Lin, Huirong Zhao, Xueli Jiao, Cong Wang, He Zhao, Lu Liu, Yu Liu, Qipeng Xie, Xing Huang, Haishan Huang and Lingling Zhao
    Citation: Cancer Cell International 2021 21:217
  36. The third-generation epithelial growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) have shown significant therapeutic effects on patients with non-small cell lung carcinoma (NSCLC) who carry active ...

    Authors: Yuting Meng, Xixi Qian, Li Zhao, Nan Li, Shengjie Wu, Baoan Chen, Tong Sun and Xuerong Wang
    Citation: Cancer Cell International 2021 21:216
  37. MicroRNAs (miRNAs) are involved in the oncogenesis, development and transformation of lung squamous cell carcinoma (LUSC). miR-665 is clinically significant and acts as a pivotal function in some cancers. Neve...

    Authors: Tian-Jun Chen, Qi Zheng, Fei Gao, Tian Yang, Hui Ren, Yang Li and Ming-Wei Chen
    Citation: Cancer Cell International 2021 21:215
  38. Chrysin has been shown to exert several beneficial pharmacological activities. Chrysin has anti-cancer, anti-viral, anti-diabetic, neuroprotective, cardioprotective, hepatoprotective, and renoprotective as wel...

    Authors: Marjan Talebi, Mohsen Talebi, Tahereh Farkhondeh, Jesus Simal-Gandara, Dalia M. Kopustinskiene, Jurga Bernatoniene and Saeed Samarghandian
    Citation: Cancer Cell International 2021 21:214
  39. Epithelial-mesenchymal transition (EMT) has been associated with wound healing, tumorigenesis, and metastasis. Circular RNAs (circRNAs) are functional non-coding RNAs involved in multiple human cancers. Howeve...

    Authors: Guili Xu, Peng Zhang, Hansi Liang, Yunhua Xu, Jian Shen, Wansheng Wang, Mingming Li, Jintao Huang, Caifang Ni, Xueguang Zhang and Xiaoli Zhu
    Citation: Cancer Cell International 2021 21:212
  40. Cancers located on the right and left sides of the colon have distinct clinical and molecular characteristics. This study aimed to explore the regulatory mechanisms of location-specific long noncoding RNAs (ln...

    Authors: Ke-zhi Li, Yi-xin Yin, Yan-ping Tang, Long Long, Ming-zhi Xie, Ji-lin Li, Ke Ding and Bang-li Hu
    Citation: Cancer Cell International 2021 21:211
  41. Emerging evidences have revealed that long non-coding RNAs (lncRNAs) have played critical roles in tumor occurrence and progression. LINC00641 has been reported to be involved in the initiation and development...

    Authors: Jianping Zhang, Shengming Jin, Wenjun Xiao, Xuchao Zhu, Chengyou Jia and Zongming Lin
    Citation: Cancer Cell International 2021 21:210
  42. The metabolic change of tumor cells is an extremely complicated process that involves the intersection and integration of various signal pathways. Compared with normal tissues, cancer cells show distinguished ...

    Authors: Yuhong Guo, Bin Lv, Renfeng Liu, Zhengzai Dai, Feifei Zhang, Yiping Liang, Bo Yu, Duo Zeng, Xiao-Bin Lv and Zhiping Zhang
    Citation: Cancer Cell International 2021 21:209

Annual Journal Metrics

  • 2022 Citation Impact
    5.8 - 2-year Impact Factor
    5.6 - 5-year Impact Factor
    0.994 - SNIP (Source Normalized Impact per Paper)
    1.145 - SJR (SCImago Journal Rank)

    2023 Speed
    34 days submission to first editorial decision for all manuscripts (Median)
    110 days submission to accept (Median)

    2023 Usage 
    2,067,719 downloads
    1,052 Altmetric mentions 

Institutional membership

Visit the membership page to check if your institution is a member and learn how you could save on article-processing charges (APCs).

Funding your APC

​​​​​​​Open access funding and policy support by SpringerOpen​​

​​​​We offer a free open access support service to make it easier for you to discover and apply for article-processing charge (APC) funding. Learn more here